A phase I study of PF-04929113 (SNX-5422), an orally bioavailable heat shock protein 90 inhibitor, in patients with refractory solid tumor malignancies and lymphomas
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Jane B Trepel Giuseppe Giaccone William Douglas Figg, Sr. Baskar Mannargudi |
| Publication date | September 9, 2011 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |